WallStSmart
MBRX

Moleculin Biotech Inc

NASDAQ: MBRX · HEALTHCARE · BIOTECHNOLOGY

$2.48
-0.40% today

Updated 2026-05-06

Market cap
$13.39M
P/E ratio
P/S ratio
EPS (TTM)
$-28.42
Dividend yield
52W range
$2 – $29
Volume
0.1M

Moleculin Biotech Inc (MBRX) Financial statements

SEC filings — annual and quarterly data.

Income statement — annual

Item20152016201720182019202020212022202320242025
Revenue$0.00$0.00$9000.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00
Revenue growth (YoY)-100.0%
Cost of revenue$0.00$6162.00$18000.00$68000.00$185000.00$285000.00$260000.00$222000.00$127000.00$126000.00$90000.00
Gross profit$0.00$-6162.00$-18000.00$-68000.00$-185000.00$-285000.00$-260000.00$-222000.00$-127000.00$-126000.00$-90000.00
Gross margin-200.0%
R&D$260417.00$1.50M$4.54M$9.73M$11.01M$12.76M$14.42M$18.97M$19.49M$17.73M$15.89M
SG&A$1.15M$2.38M$4.09M$5.30M$6.31M$6.79M$8.39M$11.54M$10.02M$8.79M$9.12M
Operating income$-738230.00$-3.88M$-8.65M$-15.03M$-17.52M$-19.74M$-22.97M$-30.64M$-29.63M$-26.64M$-25.10M
Operating margin-96144.4%
EBITDA$-738230.00$-3.88M$-8.63M$-14.96M$-13.25M$-19.54M$-22.80M$-30.51M$-29.50M$-26.52M$-25.01M
EBITDA margin-95944.4%
EBIT$-2.51M$-3.88M$-8.65M$-15.03M$-13.43M$-19.74M$-22.97M$-30.64M$-29.63M$-26.64M$-25.10M
Interest expense$0.00$43214.00$0.00$0.00$8.15M$13000.00$7.07M$1.61M
Income tax
Effective tax rate0.0%0.0%0.0%0.0%0.0%0.0%0.0%0.0%0.0%0.0%0.0%
Net income$-748360.00$-3.93M$-9.80M$-11.88M$-13.21M$-17.36M$-15.89M$-29.02M$-29.77M$-21.76M$-33.56M
Net income growth (YoY)-424.7%-149.7%-21.1%-11.2%-31.4%+8.4%-82.6%-2.6%+26.9%-54.2%
Profit margin-108944.4%